Hi Sore, a recent study in 2020 found that the mean annualized cost of Ruxolitnib for the treatment of Chronic GVHD was $$223,564, I havent seen you crying over this.
MSB's sr-aGVHD treatment licensed in Japan has a treatment cost of ~$115,000-$175,000. It will probably be priced closer to ~$200,000 in the US similar to Prochymal in Canada.
https://ashpublications.org/blood/article/136/Supplement%201/14/473080/Costs-and-Adverse-Events-Associated-with-Ibrutinib
https://www.google.com/amp/s/bioinformant.com/price-of-cell-therapy-products/amp/
- Forums
- ASX - By Stock
- Ann: COVID ARDS Trial 90-Day Survival Outcomes Presented at ISCT
Hi Sore, a recent study in 2020 found that the mean annualized...
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
-0.035(2.35%) |
Mkt cap ! $1.689B |
Open | High | Low | Value | Volume |
$1.57 | $1.58 | $1.41 | $9.712M | 6.482M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 10097 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 36383 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 20647 | 1.455 |
13 | 75326 | 1.450 |
9 | 71738 | 1.445 |
9 | 63239 | 1.440 |
3 | 77671 | 1.435 |
Price($) | Vol. | No. |
---|---|---|
1.465 | 42445 | 7 |
1.470 | 83722 | 7 |
1.475 | 26871 | 3 |
1.480 | 32024 | 5 |
1.495 | 15000 | 1 |
Last trade - 11.21am 07/10/2024 (20 minute delay) ? |
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
MSB (ASX) Chart |